Bugs as drugs, part 1: Insects. The "new" alternative medicine for the 21st century?

Alternative Medicine Review

Volumn 15, Issue 2, 2010, Pages 124-135

  Cherniack, E Paul ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANT VENOM; BEE VENOM; CANTHARIDIN; PROPOLIS; ROYAL JELLY; ANTIINFECTIVE AGENT; FATTY ACID;

ACUPUNCTURE; ALTERNATIVE MEDICINE; APHTHOUS STOMATITIS; APIPUNCTURE; ARTHRITIS; ATOPIC DERMATITIS; BURN; DIAPER DERMATITIS; HONEY; INFLAMMATION; INSECT; MAGGOT; MENOPAUSAL SYNDROME; MOLLUSCUM CONTAGIOSUM; MULTIPLE SCLEROSIS; NONHUMAN; PAIN; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; TINEA; TINEA VERSICOLOR; VERRUCA VULGARIS; WOUND HEALING; ANIMAL; ARTHRITIS, RHEUMATOID; BURNS; DEBRIDEMENT; HOT FLASHES; HUMAN; LARVA; PROCEDURES; WOUND INFECTION; WOUNDS AND INJURIES;

ANIMALS; ANTI-INFECTIVE AGENTS; ARTHRITIS, RHEUMATOID; BEE VENOMS; BURNS; DEBRIDEMENT; FATTY ACIDS; HONEY; HOT FLASHES; HUMANS; INSECTS; LARVA; PROPOLIS; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 77954655921     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Scheffler RM, Mahoney CB, Fulton BD, et al. Estimates of health care professional shortages in sub-Saharan Africa by 2015. Health Aff (Millwood) 2009;28:w849-w862.
2. Wolff H, Hansson C. Larval therapy - an effective method of ulcer debridement. Clin Exp Dermatol 2003;28:134-137. (Pubitemid 36459614)
3. Whitaker IS, Twine C, Whitaker MJ, et al. Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J 2007;83:409-413. (Pubitemid 46960827)
4. Horobin AJ, Shakesheff KM, Woodrow S, et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 2003;148:923-933.
5. Jaklic D, Lapanje A, Zupancic K, et al. Selective antimicrobial activity of maggots against pathogenic bacteria. J Med Microbiol 2008;57:617-625. (Pubitemid 351632910)
6. Turkmen A, Graham K, McGrouther DA. Therapeutic applications of the larvae for wound debridement. J Plast Reconstr Aesthet Surg 2010;63:184-188.
7. Courtenay M, Church JC, Ryan TJ. Larva therapy in wound management. J R Soc Med 2000;93:72-74.
8. Steenvoorde P, van Doom LP, Jacobi CE, Oskam J. Maggot debridement therapy in the palliative setting. Am J Hosp Palliat Care 2007;24:308-310.
9. Sherman RA, Tran JM, Sullivan R. Maggot therapy for venous stasis ulcers. Arch Dermatol 1996;132:254-256.
10. Steenvoorde P, Jacobi CE, Van Doom L, Oskam J. Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds. Ann R Coll Surg Engl 2007;89:596-602.
11. Dumville JC, Worthy G, Bland JM, et al. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009;338:b773.
12. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003;26:446-451.
13. Gray M. Is larval (maggot) debridement effective for removal of necrotic tissue from chronic wounds? J Wound Ostomy Continence Nurs 2008;35:378-384.
14. Namias N. Honey in the management of infections. Surg Infect (Larchmt) 2003;4:219-226.
15. Meda A, Lamien CE, Millogo J, et al. Therapeutic uses of honey and honeybee larvae in central Burkina Faso. J Ethnopharmacol 2004;95:103-107.
16. Basson NJ, Grobler SR. Antimicrobial activity of two South African honeys produced from indigenous Leucospermum cordifolium and Erica species on selected micro-organisms. BMC Complement Altern Med 2008;8:41.
17. Estevinho L, Pereira AP, Moreira L, et al. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 2008;46:3774-3779.
18. Oddo LP, Heard TA, Rodriguez-Malaver A, et al. Composition and antioxidant activity of Trigona carbonaria honey from Australia. J Med Food 2008;11:789-794.
19. Wang XH, Andrae L, Engeseth NJ. Antimutagenic effect of various honeys and sugars against Trp-p-1. J Agric Food Chem 2002;50:6923-6928.
20. Cutting KF. Honey and contemporary wound care: an overview. Ostomy Wound Manage 2007;53:49-54.
21. McIntosh CD, Thomson CE. Honey dressing versus paraffin tulle gras following toenail surgery. J Wound Care 2006;15:133-136.
22. Marshall C, Queen J, Manjooran J. Honey vs povidone iodine following toenail surgery. Wound UK J 2005;1:10-18.
23. Gethin G, Cowman S. Case series of use of Manuka honey in leg ulceration. Int Wound J 2005;2:10-15.
24. Gethin G, Cowman S. Manuka honey vs. hydrogel - a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs 2009;18:466-474.
25. Jull A, Walker N, Parag V, et al. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 2008;95:175-182.
26. Al-Waili NS, Saloom KY. Effects of topical honey on post-operative wound infections due to gram positive and gram negative bacteria following caesarean sections and hysterectomies. Eur J Med Res 1999;4:126-130.
27. Bardy J, Slevin NJ, Mais KL, Molassiotis A. A systematic review of honey uses and its potential value within oncology care. J Clin Nurs 2008;17:2604-2623.
28. Moore OA, Smith LA, Campbell F, et al. Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med 2001;1:2.
29. Subrahmanyam M. Topical application of honey in treatment of burns. Br J Surg 1991;78:497-498.
30. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns 1998;24:157-161. (Pubitemid 28233917)
31. Subrahmanyam M. Honey impregnated gauze versus polyurethane film (OpSite) in the treatment of burns - a prospective randomised study. Br J Plast Surg 1993;46:322-323.
32. Subrahmanyam M. Honey dressing versus boiled potato peel in the treatment of burns: a prospective randomized study. Burns 1996;22:491-493. (Pubitemid 26306116)
33. Subrahmanyam M. Honey-impregnated gauze versus amniotic membrane in the treatment of burns. Burns 1994;20:331-333. (Pubitemid 24235460)
34. Jull AB, Rodgers A, Walker N. Honey as a topical treatment for wounds. Cochrane Database Syst Rev 2008(4):CD005083.
35. Al-Waili NS. Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff. Eur J Med Res 2001;6:306-308.
36. Kilicoglu B, Kismet K, Koru O, et al. The scolicidal effects of honey. Adv Ther 2006;23:1077-1083.
37. Kilicoglu B, Kismet K, Kilicoglu SS, et al. Effects of honey as a scolicidal agent on the hepatobiliary system. World J Gastroenterol 2008;14:2085-2088.
38. Nilforoushzadeh MA, Jaffary F, Moradi S, et al. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis. BMC Complement Altern Med 2007;7:13.
39. Al-Waili NS. An alternative treatment for pityriasis versicolor, tinea cruris, tinea corporis and tinea faciei with topical application of honey, olive oil and beeswax mixture: an open pilot study. Complement Ther Med 2004;12:45-47.
40. Boukraa L, Benbarek H, Aissat S. Synergistic action of starch and honey against Pseudomonas aeruginosa in correlation with diastase number. J Altern Complement Med 2008;14:181-184. (Pubitemid 351364401)
41. Haffejee IE, Moosa A. Honey in the treatment of infantile gastroenteritis. Br Med J (Clin Res Ed) 1985;290:1866-1867.
42. Prakash A, Medhi B, Avti PK, et al. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats. Phytother Res 2008;22:1511-1519. (Pubitemid 352789623)
43. Rajan TV, Tennen H, Lindquist RL, et al. Effect of ingestion of honey on symptoms of rhinoconjunctivitis. Ann Allergy Asthma Immunol 2002;88:198-203. (Pubitemid 34165032)
44. Al-Waili NS. Mixture of honey, beeswax and olive oil inhibits growth of Staphylococcus aureus and Candida albicans. Arch Med Res 2005;36:10-13.
45. Al-Waili NS. Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study. Complement Ther Med 2003;11:226-234.
46. Al-Waili NS. Clinical and mycological benefits of topical application of honey, olive oil and beeswax in diaper dermatitis. Clin Microbiol Infect 2005;11:160-163.
47. Molina V, Carbajal D, Arruzazabala L, Mas R. Therapeutic effect of D-002 (abexol) on gastric ulcer induced experimentally in rats. J Med Food 2005;8:59-62.
48. Mendoza S, Noa M, Perez Y, Mas R. Preventive effect of D-002, a mixture of long-chain alcohols from beeswax, on the liver damage induced with CC14 in rats. J Med Food 2007;10:379-383.
49. Suzuki KM, Isohama Y, Maruyama H, et al. Estrogenic activities of fatty acids and a sterol isolated from royal jelly. Evid Based Complement Alternat Med 2008;5:295-302.
50. Leung R, Ho A, Chan J, et al. Royal jelly consumption and hypersensitivity in the community. Clin Exp Allergy 1997;27:333-336.
51. Miyata T. Pharmacological basis of traditional medicines and health supplements as curatives. J Pharmacol Sci 2007;103:127-131.
52. Mishima S, Suzuki KM, Isohama Y, et al. Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol 2005;101:215-220.
53. Calli C, Tugyan K, Oncel S, et al. Effectiveness of royal jelly on tympanic membrane perforations: an experimental study. J Otolaryngol Head Neck Surg 2008;37:179-184.
54. Kamakura M, Suenobu N, Fukushima M. Fifty-seven-kDa protein in royal jelly enhances proliferation of primary cultured rat hepatocytes and increases albumin production in the absence of serum. Biochem Biophys Res Commun 2001;282:865-874.
55. Sver L, Orsolic N, Tadic Z, et al. A royal jelly as a new potential immunomodulator in rats and mice. Comp Immunol Microbiol Infect Dis 1996;19:31-38.
56. Mannoor MK, Shimabukuro I, Tsukamotoa M, et al. Honeybee royal jelly inhibits autoimmunity in SLE-prone NZB x NZW F1 mice. Lupus 2009;18:44-52.
57. Boukraa L. Additive activity of royal jelly and honey against Pseudomonas aeruginosa. Altern Med Rev 2008;13:330-333.
58. Boukraa L, Niar A, Benbarek H, Benhanifia M. Additive action of royal jelly and honey against Staphylococcus aureus. J Med Food 2008;11:190-192. (Pubitemid 351450503)
59. Lerrer B, Zinger-Yosovich KD, Avrahami B, Gilboa-Garber N. Honey and royal jelly, like human milk, abrogate lectin-dependent infection-preceding Pseudomonas aeruginosa adhesion. ISME J 2007;1:149-155. (Pubitemid 46878157)
60. Okamoto I, Taniguchi Y, Kunikata T, et al. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci 2003;73:2029-2045.
61. Tokunaga KH, Yoshida C, Suzuki KM, et al. Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol Pharm Bull 2004;27:189-192.
62. Vittek J. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 1995;51:927-935.
63. Georgiev DB, Metka M, Huber JC, et al. Effects of an herbal medication containing bee products on menopausal symptoms and cardiovascular risk markers: results of a pilot open-uncontrolled trial. MedGenMed 2004;6:46.
64. Thien FC, Leung R, Baldo BA, et al. Asthma and anaphylaxis induced by royal jelly. Clin Exp Allergy 1996;26:216-222. (Pubitemid 26061074)
65. O'Connor R, Peck L. Chem I supplement: Bee sting: the chemistry of an insect venom. J Chem Educ 1980;57:206-209.
66. Jang HS, Chung HS, Ko E, et al. Microarray analysis of gene expression profiles in response to treatment with bee venom in lipopolysaccharide activated RAW 264.7 cells. J Ethnopharmacol 2009;121:213-220.
67. Kang SS, Pak SC, Choi SH. The effect of whole bee venom on arthritis. Am J Chin Med 2002;30:73-80.
68. Yoon SY, Kwon YB, Kim HW, et al. Bee venom injection produces a peripheral anti-inflammatory effect by activation of a nitric oxide-dependent spinocoeruleus pathway. Neurosci Lett 2008;430:163-168.
69. Son DJ, Lee JW, Lee YH, et al. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther 2007;115:246-270.
70. Yoon SY, Kwon YB, Kim HW, et al. Peripheral bee venom's anti-inflammatory effect involves activation of the coeruleospinal pathway and sympathetic preganglionic neurons. Neurosci Res 2007;59:51-59.
71. Park HJ, Lee SH, Son DJ, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum 2004;50:3504-3515.
72. Hong SJ, Rim GS, Yang HI, et al. Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon 2005;46:39-45.
73. Seo SW, Jung WS, Lee SE, et al. Effects of bee venom on cholecystokinin octapeptide-induced acute pancreatitis in rats. Pancreas 2008;36:e22-e29.
74. Castro HJ, Mendez-Lnocencio JI, Omidvar B, et al. A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis. Allergy Asthma Proc 2005;26:470-476. (Pubitemid 43105898)
75. Wesselius T, Heersema DJ, Mostert JP, et al. A randomized crossover study of bee sting therapy for multiple sclerosis. Neurology 2005;65:1764-1768.
76. Luo C, Chen J, Li HL, Li JS. Spatial and temporal expression of c-Fos protein in the spinal cord of anesthetized rat induced by subcutaneous bee venom injection. Brain Res 1998;806:175-185. (Pubitemid 29010492)
77. Kwon YB, Lee JD, Lee HJ, et al. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 2001;90:271-280.
78. Lee SH, Lee HJ, Baek YH, et al. Effects of bee venom on the pain, edema, and acute inflammatory reactant of rheumatoid arthritic patients. J Kor Acu Mox Soc 2003;20:77-84.
79. Lazner F, Gowen M, Kola I. An animal model for pycnodysostosis: the role of cathepsin K in bone remodelling. Mol Med Today 1999;5:413-414. (Pubitemid 29399991)
80. Lee JD, Park HJ, Chae Y, Lim S. An overview of bee venom acupuncture in the treatment of arthritis. Evid Based Complement Alternat Med 2005;2:79-84.
81. Altaian RD, Schultz DR, Collins-Yudiskas B, et al. The effects of a partially purified fraction of an ant venom in rheumatoid arthritis. Arthritis Rheum 1984;27:277-284.
82. Uckan F, Sinan S, Savasci S, Ergin E. Determination of venom components from the endoparasitoid wasp Pimpla turionellae L. (Hymenoptera: Ichneumonidae). Ann Entomol Soc Am 2004;97:775-780.
83. Saini SS, Peterson JW, Chopra AK. Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity. Biochem Biophys Res Commun 1997;238:436-442.
84. Stuhlmeier KM. Apis mellifera venom and melittin block neither NF-kappa B-p50-DNA interactions nor the activation of NF-kappa B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. J Immunol 2007;179:655-664.
85. Nah SS, Ha E, Lee HJ, Chung JH. Inhibitory effects of melittin on the production of lipopolysaccharide-induced matrix metalloproteinase 3 in human osteoarthritic chondrocytes. Toxicon 2007;49:881-885.
86. Ovcharov R, Shkenderov S, Mihailova S. Anti-inflammatory effects of apamin. Toxicon 1976;14:441-447.
87. Shkenderov S, Koburova K. Adolapin - a newly isolated analgetic and anti-inflammatory polypeptide from bee venom. Toxicon 1982;20:317-321.
88. Yibin G, Jiang Z, Hong Z, et al. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro. Biochem Pharmacol 2005;70:209-219.
89. Khalil ML. Biological activity of bee propolis in health and disease. Asian Pac J Cancer Prev 2006;7:22-31.
90. Silici S, Kutluca S. Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. J Ethnopharmacol 2005;99:69-73.
91. Farnesi AP, Aquino-Ferreira R, De Jong D, et al. Effects of stingless bee and honey bee propolis on four species of bacteria. Genet Mol Res 2009;8:635-640.
92. Kartal M, Yildiz S, Kaya S, et al. Antimicrobial activity of propolis samples from two different regions of Anatolia. J Ethnopharmacol 2003;86:69-73.
93. Schnitzler P, Neuner A, Nolkemper S, et al. Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother Res 2010;24:S20-S28.
94. Song YS, Jin C, Jung KJ, Park EH. Estrogenic effects of ethanol and ether extracts of propolis. J Ethnopharmacol 2002;82:89-95.
95. Gekker G, Hu S, Spivak M, et al. Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures. J Ethnopharmacol 2005;102:158-163.
96. Mishima S, Narita Y, Chikamatsu S, et al. Effects of propolis on cell growth and gene expression in HL-60 cells. J Ethnopharmacol 2005;99:5-11.
97. Liberio SA, Pereira AL, Araujo MJ, et al. The potential use of propolis as a cariostatic agent and its actions on mutans group Streptococci. J Ethnopharmacol 2009;125:1-9.
98. Steinberg D, Kaine G, Gedalia I. Antibacterial effect of propolis and honey on oral bacteria. Am J Dent 1996;9:236-239.
99. Murray MC, Worthington HV, Blinkhorn AS. A study to investigate the effect of a propolis-containing mouthrinse on the inhibition of de novo plaque formation. J Clin Periodontol 1997;24:796-798.
100. Samet N, Laurent C, Susarla SM, Samet-Rubinsteen N. The effect of bee propolis on recurrent aphthous stomatitis: a pilot study. Clin Oral Investig 2007;11:143-147.
101. Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol 2001;137:1357-1360.
102. Efferth T, Rauh R, Kahl S, et al. Molecular modes of action of cantharidin in tumor cells. Biochem Pharmacol 2005;69:811-818.
103. Rauh R, Kahl S, Boechzelt H, et al. Molecular biology of cantharidin in cancer cells. Chin Med 2007;2:8.
104. Dorn DC, Kou CA, Png KJ, Moore MA. The effect of cantharidins on leukemic stem cells. Int J Cancer 2009;124:2186-2199.
105. Liu D, Chen Z. The effects of cantharidin and cantharidin derivates on tumour cells. Anticancer Agents Med Chem 2009;9:392-396.
106. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Hepatobiliary Pancreat Dis Int 2007;6:72-80.
107. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells. Hepatobiliary Pancreat Dis Int 2004;3:603-607.
108. Wang CC, Wu CH, Hsieh KJ, et al. Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology 2000;147:77-87.
109. Peng F, Wei YQ, Tian L, et al. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol 2002;128:223-230.
110. Chen YJ, Shieh CJ, Tsai TH, et al. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells. Anticancer Drugs 2005;16:293-299.
111. Kok SH, Cheng SJ, Hong CY, et al. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett 2005;217:43-52.
112. Hill TA, Stewart SG, Sauer B, et al. Heterocyclic substituted cantharidin and norcantharidin analogues - synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. Bioorg Med Chem Lett 2007;17:3392-3397.
113. Hill TA, Stewart SG, Ackland SP, et al. Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation. Bioorg Med Chem 2007;15:6126-6134.
114. Sagawa M, Nakazato T, Uchida H, et al. Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathway. Cancer Sci 2008;99:1820-1826.
115. Zheng LH, Bao YL, Wu Y, et al. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression. Cancer Lett 2008;272:102-109.
116. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol 2000;43:503-507.
117. Smith AG, Powis RA, Pritchard DI, Britland ST. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds. Biotechnol Prog 2006;22:1690-1696.
118. Gowda DV, Ravi V, Shivakumar HG, Hatna S. Preparation, evaluation and bioavailability studies of indomethacin-bees wax microspheres. J Mater Sci Mater Med 2009;20:1447-1456.
119. Soares MO, Iglesias CP, Bland JM, et al. Cost effectiveness analysis of larval therapy for leg ulcers. BMJ 2009;338:b825.
120. Pemberton RW. Insects and other arthropods used as drugs in Korean traditional medicine. J Ethnopharmacol 1999;65:207-216.